Abderrazzak Merzouki
Chief Tech/Sci/R&D Officer presso SUNSHINE BIOPHARMA, INC.
Patrimonio netto: 7 003 $ in data 31/03/2024
Profilo
Abderrazzak Merzouki is currently the Chief Science Officer & Director at Sunshine Biopharma, Inc. since 2016.
He is also currently a Senior Scientist at Imperial College London since 2007.
Previously, he worked as the Director-Cell Engineering & Biotherapeutics at Hydrogen Future Corp.
Dr. Merzouki holds a graduate and doctorate degree from the University of Quebec and a doctorate degree from Institut Armand-Frappier.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/03/2024 | 116 720 ( 0.12% ) | 7 003 $ | 31/03/2024 |
Posizioni attive di Abderrazzak Merzouki
| Società | Posizione | Inizio |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 25/01/2024 |
| Imperial College London | Corporate Officer/Principal | 04/02/2011 |
Precedenti posizioni note di Abderrazzak Merzouki
| Società | Posizione | Fine |
|---|---|---|
| HYDROGEN FUTURE CORP | Corporate Officer/Principal | - |
Formazione di Abderrazzak Merzouki
| University of Quebec | Doctorate Degree |
| Institut Armand-Frappier | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Hydrogen Future Corp.
 Hydrogen Future Corp. Agricultural Commodities/MillingProcess Industries Hydrogen Future Corp. operates as a holding company. The firm engages in the provision of contract research and laboratory services. It provides alternate energy generation products and services. The company was founded on June 21, 2006 and is headquartered in Houston, TX. | Process Industries |
- Borsa valori
- Insiders
- Abderrazzak Merzouki
